Evidence map›Paper›PMID 40971824›Full record

ArticlePloS one2025

Acute radiation exposure in mice reveals traces of oxidation-mediated modifications in serum albumin.

Masaru Yamaguchi, Yota Tatara, Yoshiaki Sato, Ikuo Kashiwakura

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Masaru YamaguchiHirosaki University Graduate School of Health Sciences, Hirosaki, Japan.ORCID https://orcid.org/0000-0002-8623-6596
Yota TataraHirosaki University Graduate School of Medicine, Hirosaki, Japan.
Yoshiaki SatoUniversity of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States of America.ORCID https://orcid.org/0000-0003-3375-5189
Ikuo KashiwakuraHirosaki University Graduate School of Health Sciences, Hirosaki, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High doses of ionizing radiation induce specific oxidation-mediated modifications on the sequence of amino acid that constitutes serum albumin, but the time-dependent response thereafter is unclear. We, therefore, used liquid chromatography coupled with tandem mass spectrometry to profile oxidation-mediated modifications in serum collected from mice subjected to total body X-ray irradiation (TBI) at 20-day intervals up to day 80. In TBI mice, albumin structural regions were generally glycated and oxidatively modified, and in particular, oxidative modifications of serum albumin (OMSA) were observed on either analysis day in eight sequences containing the following amino acid residues: OMSA9 (oxidation of lysine residue (Lys)-97), OMSA12 (oxidation of methionine residue (Met)-147), OMSA21 (oxidation of tyrosine residue (Tyr)-287), OMSA22 (oxidation of proline residue (Pro)-306), OMSA25 (oxidation of Lys-310), OMSA29 (oxidation of Pro-390), OMSA40 (oxidation of Tyr-476), and OMSA39 (nitration of Tyr-476). Interestingly, some significant OMSA sequences induced by TBI were maintained even after 41 times the half-life of albumin. These results suggest that exposure to ionizing radiation induces specific oxidative modifications in serum albumin, and there are specific amino acid residues that are sensitive to these modifications. Furthermore, these could be applied as novel biomarkers to estimate the presence or history of radiation exposure.

Indexed as

Serum AlbuminAnimalsChromatography, LiquidMaleMiceOxidation-ReductionTandem Mass SpectrometryWhole-Body IrradiationX-RaysSerum Albumin

Identifiers

PMID40971824
PMCPMC12448996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.